Lobbying registrant · LDA.gov number 304736
TARPLIN, DOWNS & YOUNG, LLC
83 reportsConfirmed from the official record
TARPLIN, DOWNS & YOUNG, LLC is named as the registrant in 83 lobbying reports we hold for 2026-Q2, for 77 clients. 0 reports of 77 compared with the due date were posted after it.
Clients and amounts
A lobbying report states the registrant's income from the client (a lobbying firm) or its own lobbying expenses (an organization lobbying for itself), for the whole quarter and every issue together. A report of less than $5,000, or of no lobbying activity, states no figure. It is not the amount spent on one bill.
| Client, sort A to Z | Amount the report states, by quarter, sort largest first | Reports, sort smallest first |
|---|---|---|
| ACTUM ON BEHALF OF HEALTHEQUITY, INC. | 2026-Q2: $50,000 in income | 2 |
| AMERICAN ACADEMY OF HOME CARE MEDICINE | 2026-Q2: $70,000 in income | 2 |
| ASTELLAS PHARMA US, INC | 2026-Q2: $80,000 in income | 2 |
| MATHEMATICA, INC | 2026-Q2: $60,000 in income | 2 |
| PHRMA | 2026-Q2: $80,000 in income | 2 |
| RAYNER SURGICAL INC. | 2026-Q2: $60,000 in income | 2 |
| ABBOTT (FORMERLY KNOWN AS ALERE INC.) | 2026-Q2: $80,000 in income | 1 |
| ABBVIE INC. | 2026-Q2: $60,000 in income | 1 |
| ADULT VACCINE ACCESS COALITION | 2026-Q2: $60,000 in income | 1 |
| ADVAMED | 2026-Q2: $80,000 in income | 1 |
| ALZHEIMER'S ASSOCIATION | 2026-Q2: $80,000 in income | 1 |
| AMAZON.COM SERVICES LLC | 2026-Q2: $80,000 in income | 1 |
| AMERICAN CANCER SOCIETY CANCER ACTION NETWORK (ACSCAN) | 2026-Q2: $80,000 in income | 1 |
| AMERICAN COLLEGE OF PHYSICIANS | 2026-Q2: $80,000 in income | 1 |
| AMERICAN INVESTMENT COUNCIL | 2026-Q2: $80,000 in income | 1 |
| AMERICAN OSTEOPATHIC ASSOCIATION | 2026-Q2: $80,000 in income | 1 |
| AMGEN INC | 2026-Q2: $60,000 in income | 1 |
| AMNEAL PHARMACEUTICALS, INC. | 2026-Q2: $60,000 in income | 1 |
| AMYLYX PHARMACEUTICALS | 2026-Q2: $40,000 in income | 1 |
| ASTRAZENECA | 2026-Q2: $80,000 in income | 1 |
| AVAILITY | 2026-Q2: $80,000 in income | 1 |
| BIOTECHNOLOGY INDUSTRY ORGANIZATION | 2026-Q2: $80,000 in income | 1 |
| BLUE CROSS BLUE SHIELD ASSOCIATION | 2026-Q2: $110,000 in income | 1 |
| BOEHRINGER INGELHEIM | 2026-Q2: $70,000 in income | 1 |
| BREAKTHROUGH T1D (FKA JUVENILE DIABETES RESEARCH FOUNDATION INTERNATIONAL) | 2026-Q2: $80,000 in income | 1 |
| BRISTOL MYERS SQUIBB | 2026-Q2: $80,000 in income | 1 |
| CALIFORNIA PROTONS CANCER THERAPY CENTER | 2026-Q2: $80,000 in income | 1 |
| CARDINAL HEALTH (F.K.A. THE GLOVER PARK GROUP) | 2026-Q2: $16,000 in income | 1 |
| CHAPTER | 2026-Q2: $50,000 in income | 1 |
| COTIVITI, INC. | 2026-Q2: $80,000 in income | 1 |
| CRINETICS PHARMACEUTICALS | 2026-Q2: $60,000 in income | 1 |
| CULINA HEALTH | 2026-Q2: $60,000 in income | 1 |
| ELEVANCE HEALTH, INC (F.K.A. ANTHEM, INC. & WELLPOINT, INC.) | 2026-Q2: $80,000 in income | 1 |
| ELI LILLY AND COMPANY | 2026-Q2: $60,000 in income | 1 |
| EXCELLUS HEALTH PLAN, INC. | 2026-Q2: $80,000 in income | 1 |
| FLAGSHIP PIONEERING | 2026-Q2: $80,000 in income | 1 |
| FOUNDATION MEDICINE | 2026-Q2: $80,000 in income | 1 |
| GAINWELL TECHNOLOGIES (FKA HEALTH MANAGEMENT SYSTEMS) | 2026-Q2: $80,000 in income | 1 |
| GENENTECH, INC. | 2026-Q2: $60,000 in income | 1 |
| GENERAL CATALYST | 2026-Q2: $60,000 in income | 1 |
| GENTIVA (FORMERLY REPORTED AS HUMANA & KINDRED AT HOME) | 2026-Q2: $60,000 in income | 1 |
| GILEAD SCIENCES, INC. | 2026-Q2: $80,000 in income | 1 |
| H2 HEALTH | 2026-Q2: $80,000 in income | 1 |
| HANSA BIOPHARMA | 2026-Q2: $60,000 in income | 1 |
| HEALTH CARE SERVICE CORPORATION | 2026-Q2: $50,000 in income | 1 |
| HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) | 2026-Q2: $90,000 in income | 1 |
| IDORSIA PHARMACEUTICALS US INC | 2026-Q2: $50,000 in income | 1 |
| IMMIX BIOPHARMA INC | 2026-Q2: $20,000 in income | 1 |
| JAZZ PHARMACEUTICALS INC. | 2026-Q2: $80,000 in income | 1 |
| LANTHEUS | 2026-Q2: $60,000 in income | 1 |
Lobbyists named in these reports
- CHARLOTTE SPEARS IVANCIC · 57 reports · earlier government job reported
- ELIZABETH T MURRAY · 42 reports · earlier government job reported
- EMILY H MURRY · 50 reports · earlier government job reported
- JEFF RECZEK · 15 reports · earlier government job reported
- JENNIFER B YOUNG · 53 reports · earlier government job reported
- MARGARET JOSEPH · 38 reports · earlier government job reported
- PAMELA SMITH · 38 reports · earlier government job reported
- PARICK BRAERTON CARROLL · 39 reports · earlier government job reported
- PETER FISE · 53 reports · earlier government job reported
- RAISSA H DOWNS · 42 reports · earlier government job reported
Bills named, and how the House and the Senate voted
1 bill named in these reports. None of them became law in our record, so no recorded vote is shown. A lobbying report names the houses of Congress and the agencies the lobbyists contacted. It does not say which members or staff they met.
| Bill | Status | How the House and the Senate voted |
|---|---|---|
| H.R. 2853Combating Organized Retail Crime Act of 2025 | Passed the House | No recorded vote in our record |
Issues named: Health Issues (66), Medicare/Medicaid (62), Budget/Appropriations (37), Taxation/Internal Revenue Code (6), Trade (domestic/foreign) (4), Pharmacy (1), Veterans (1).
Every report
| Client, sort A to Z | Kind, as filed, sort A to Z | Posted, sort oldest first | Report |
|---|---|---|---|
| SANOFI US SERVICES INC (FORMERLY KNOWN AS GENZYME CORPORATION)Budget/Appropriations, Medicare/Medicaid, Health Issues | 2nd Quarter - Report | The report on LDA.gov | |
| CALIFORNIA PROTONS CANCER THERAPY CENTERMedicare/Medicaid | 2nd Quarter - Report | The report on LDA.gov | |
| RAYNER SURGICAL INC.Medicare/Medicaid | 2nd Quarter - ReportA later report for this client and quarter replaces it | The report on LDA.gov | |
| PHREESIABudget/Appropriations, Health Issues, Medicare/Medicaid | 2nd Quarter - Report | The report on LDA.gov | |
| NATIONAL SEATING & MOBILITYHealth Issues, Medicare/Medicaid | 2nd Quarter - Report | The report on LDA.gov | |
| NOVOCURE INC.Medicare/Medicaid, Health Issues | 2nd Quarter - Report | The report on LDA.gov | |
| NEUROCRINE BIOSCIENCES, INC.Health Issues, Medicare/Medicaid, Budget/Appropriations | 2nd Quarter - Report | The report on LDA.gov | |
| LONGEVITY HEALTH PLANHealth Issues, Medicare/Medicaid | 2nd Quarter - Report | The report on LDA.gov | |
| LINCAREMedicare/Medicaid, Budget/Appropriations | 2nd Quarter - Report | The report on LDA.gov | |
| HANSA BIOPHARMABudget/Appropriations, Health Issues | 2nd Quarter - Report | The report on LDA.gov | |
| GENENTECH, INC.Medicare/Medicaid, Health Issues, Budget/Appropriations | 2nd Quarter - Report | The report on LDA.gov | |
| ELI LILLY AND COMPANYMedicare/Medicaid, Budget/Appropriations, Health Issues | 2nd Quarter - Report | The report on LDA.gov | |
| CARDINAL HEALTH (F.K.A. THE GLOVER PARK GROUP)Health Issues, Budget/Appropriations | 2nd Quarter - Report | The report on LDA.gov | |
| BOEHRINGER INGELHEIMBudget/Appropriations, Medicare/Medicaid, Health Issues | 2nd Quarter - Report | The report on LDA.gov | |
| ASTRAZENECABudget/Appropriations, Medicare/Medicaid, Health Issues | 2nd Quarter - Report | The report on LDA.gov | |
| AMYLYX PHARMACEUTICALSHealth Issues, Medicare/Medicaid | 2nd Quarter - Report | The report on LDA.gov | |
| AMGEN INCHealth Issues, Medicare/Medicaid, Budget/Appropriations | 2nd Quarter - Report | The report on LDA.gov | |
| ADVAMEDHealth Issues, Medicare/Medicaid | 2nd Quarter - Report | The report on LDA.gov | |
| AMERICAN CANCER SOCIETY CANCER ACTION NETWORK (ACSCAN)Health Issues, Budget/Appropriations, Medicare/Medicaid | 2nd Quarter - Report | The report on LDA.gov | |
| ABBOTT (FORMERLY KNOWN AS ALERE INC.)Budget/Appropriations, Health Issues, Medicare/Medicaid, Trade (domestic/foreign) | 2nd Quarter - Report | The report on LDA.gov | |
| NATIONAL COMPREHENSIVE CANCER NETWORKMedicare/Medicaid, Health Issues | 2nd Quarter - Report | The report on LDA.gov | |
| ADULT VACCINE ACCESS COALITIONHealth Issues, Budget/Appropriations | 2nd Quarter - Report | The report on LDA.gov | |
| AMNEAL PHARMACEUTICALS, INC.Health Issues, Budget/Appropriations | 2nd Quarter - Report | The report on LDA.gov | |
| VERTEX PHARMACEUTICALS INCORPORATEDBudget/Appropriations, Health Issues, Medicare/Medicaid | 2nd Quarter - Report | The report on LDA.gov | |
| QUEST DIAGNOSTICSHealth Issues, Medicare/Medicaid, Budget/Appropriations | 2nd Quarter - Report | The report on LDA.gov | |
| MATHEMATICA, INCMedicare/Medicaid | 2nd Quarter - ReportA later report for this client and quarter replaces it | The report on LDA.gov | |
| GENTIVA (FORMERLY REPORTED AS HUMANA & KINDRED AT HOME)Health Issues, Medicare/Medicaid | 2nd Quarter - Report | The report on LDA.gov | |
| GAINWELL TECHNOLOGIES (FKA HEALTH MANAGEMENT SYSTEMS)Medicare/Medicaid, Budget/Appropriations, Health Issues | 2nd Quarter - Report | The report on LDA.gov | |
| GENERAL CATALYSTMedicare/Medicaid | 2nd Quarter - Report | The report on LDA.gov | |
| FOUNDATION MEDICINEHealth Issues, Medicare/Medicaid, Trade (domestic/foreign) | 2nd Quarter - Report | The report on LDA.gov | |
| COTIVITI, INC.Medicare/Medicaid | 2nd Quarter - Report | The report on LDA.gov | |
| CHAPTERMedicare/Medicaid | 2nd Quarter - Report | The report on LDA.gov | |
| AVAILITYMedicare/Medicaid, Health Issues | 2nd Quarter - Report | The report on LDA.gov |
Campaign gifts this registrant reported
Lobbyists and registrants report their political contributions twice a year (form LD-203). We hold these reports only for contributions to the campaign committees of members who sponsored or cosponsored a bill named in a lobbying report. Any other contribution: Not checked yet.
No contribution report we hold lists a gift from this filer.
Where this comes from
Lobbying Disclosure Act reports (LD-2), LDA.gov. We save our own copy of each page of LDA.gov's list of reports before we read it. These pages were built from our copies on .
2026-Q2: every page of LDA.gov's list saved and read.
A lobbying report states the registrant's income from the client (a lobbying firm) or its own lobbying expenses (an organization lobbying for itself), for the whole quarter and every issue together. A report of less than $5,000, or of no lobbying activity, states no figure. It is not the amount spent on one bill.
Senate Office of Public Records cannot vouch for the data or analyses derived from these data after the data have been retrieved from LDA.gov.